American Federation for Aging Research   Report issue

Foundation Phase 2
Founded: New York NY United States (1981)

Organization Overview

First Clinical Trial
2002
NCT00202462
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

simvastatin (zocor) (1 trial)

Drugs in Other Trials (3)

corn (1 trial)

icosapent ethyl (vascepa) (1 trial)

testosterone (delatestryl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4